Filing of Statement of deviation & variation is not applicable to the Company for the quarter ended 31.03.2026.

BALPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-11.4%1-day move

₹96.07

prior close

₹91.89

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.4-0.4-0.6-0.4-11.4-9.3-9.3-9.3-10.0-9.4-10.4-17.6——

Up moveDown movePending

AI summary

Bal Pharma Ltd has filed a clarification with BSE and NSE stating that the Statement of Deviation/Variation is not applicable for the quarter ended 31 March 2026. The company clarified that it has neither raised any funds through public issue, rights issue, preferential issue, QIP, or any other mode during this period. Additionally, there are no proceeds from earlier issues that remain outstanding for utilization. This filing is made under SEBI (LODR) Regulation 32(1) as a routine compliance disclosure.

Likely market impact

No impact on shareholders or stock price. This is a standard regulatory compliance filing confirming the company did not raise any capital and therefore has no fund utilization to report.